Xi Chen
- Cancer Research top 0.1%
- Cancer-related molecular mechanisms research 79
- MicroRNA in disease regulation 45
- Cancer, Hypoxia, and Metabolism 26
- Cell Biology top 0.1%
- Molecular Biology top 0.2%
- RNA modifications and cancer 78
- Circular RNAs in diseases 35
- RNA Research and Splicing 32
- Epigenetics and DNA Methylation 32
- Cancer-related gene regulation 20
- Oncology top 0.5%
- Immunology top 1%
- Co-authors
- Yu ShyrBrian D. LehmannJennifer A. PietenpolMelinda E. SandersRon PrywesJoshua A. BauerA. Bapsi ChakravarthyJuan R. Cubillos‐Ruiz
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xi Chen
325 papers receiving 19.9k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Cancer Research 5.8k
- Cell Biology 4.3k
- Molecular Biology 11.7k
- Oncology 4.5k
- Immunology 2.4k
Countries citing papers authored by Xi Chen
This map shows the geographic impact of Xi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Chen more than expected).
Fields of papers citing papers by Xi Chen
This network shows the impact of papers produced by Xi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Chen. The network helps show where Xi Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 1 | |
| 8 | METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progressionbreakdown → | 2023 | 99 |
| 9 | 2023 | 25 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 43 | |
| 13 | 2020 | 60 | |
| 14 | 2019 | 22 | |
| 15 | 2018 | 68 | |
| 16 | 2018 | 36 | |
| 17 | 2018 | 25 | |
| 18 | 2018 | 7 | |
| 19 | 2018 | 38 | |
| 20 | 2017 | 59 |
About Xi Chen
Xi Chen is a scholar working on Cancer Research, Molecular Biology, Hematology, Cell Biology and Immunology, having authored 346 papers that have together received 20.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (79 papers), RNA modifications and cancer (78 papers), MicroRNA in disease regulation (45 papers), Circular RNAs in diseases (35 papers), RNA Research and Splicing (32 papers), Epigenetics and DNA Methylation (32 papers), Cancer, Hypoxia, and Metabolism (26 papers) and Cancer-related gene regulation (20 papers). The work is most often cited by research in Cancer Research (5.8k citations), Cell Biology (4.3k citations), Molecular Biology (11.7k citations), Oncology (4.5k citations) and Immunology (2.4k citations). Xi Chen has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Yu Shyr, Brian D. Lehmann, Jennifer A. Pietenpol, Melinda E. Sanders, Ron Prywes, Joshua A. Bauer, A. Bapsi Chakravarthy, Juan R. Cubillos‐Ruiz, Jingshi Shen and Linda M. Hendershot. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, Cancer Research, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.